HRSA approves 10 drugmakers for 340B rebate model pilot program
HRSA announced Oct. 1 that it has approved 10 drugmakers to participate in a revised 340B Rebate Model Pilot Program, which will replace the traditional upfront 340B discount with a post-sale rebate structure for a limited set of drugs starting Jan. 1, 2027. Here are five things to know: The post HRSA approves 10 drugmakers for 340B rebate model pilot program appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.